Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

poLight ASA Confirms Design-win for TLens® in SnkeXR Medical AR Glasses

poLight

Tønsberg, Norway 31 October 2025 – poLight ASA (OSE:PLT) today announced that its TLens® tunable lens technology is used in the SnkeXR augmented reality (AR) headset purpose-built for medical applications. The device will be unveiled on 4 November at the 2025 Medical Extended Reality Summit.

“We congratulate Snke on the launch of their SnkeXR device,” said Dr. Øyvind Isaksen, CEO of poLight ASA. “This is yet another validation of poLight’s technology lead in the optics for the AR|MR market, and demonstrates our ongoing commitment to enabling innovative and groundbreaking applications in medical markets.”

Nissan Elimelech, General Manager of Snke XR said “working with poLight TLens® technology has enabled Snke XR to deliver the best possible camera performance and accelerate the adoption and integration of AR technologies into medical devices and workflows. This powerful hardware foundation ensures reliable performance in demanding clinical environments and enables the creation of sophisticated medical applications.”

This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 17. The information was submitted for publication at 2025-10-31 08:15 CET.

For further information, please contact:
Dr Øyvind Isaksen, CEO, poLight ASA: +47 90 87 63 98

About poLight ASA
poLight ASA (listed on the Oslo Stock Exchange: PLT) offers a patented, proprietary tunable optics technology, starting with its first product, TLens® which replicates "the human eye" experience in autofocus cameras used in devices such as smartphones, wearables, barcode scanners, machine vision systems and various medical equipment. poLight's TLens® enables better system performance and new user experiences due to benefits such as extremely fast focus, small footprint, no magnetic interference, low power consumption and constant field of view. poLight is based in Tønsberg, Norway, with employees in Finland, France, UK, US, China, Taiwan, Japan, and the Philippines. For more information, please visit https://www.polight.com

About SNKE
Spun out of Brainlab in June 2025, Snke is transforming healthtech with scalable, data-driven innovation powered by AI and big data. We’re more than 300 experts specializing in healthcare IT, advanced visualization and simulation, data science and machine learning. Our newest product is the SnkeXR glasses.

SnkeXR is a neutral, open-platform augmented reality (AR) headset purpose-built for the medical industry. It is designed to facilitate and accelerate the adoption and integration of AR technologies into medical devices and workflows. With SnkeXR, medical device companies can develop and deploy customized applications directly on the glasses, or seamlessly connect their devices to enhance performance, functionality, and user experience.

Equipped with multiple high-precision sensors and advanced features, SnkeXR delivers real-time spatial awareness, accurate tracking, and intuitive interaction capabilities. This powerful hardware foundation ensures reliable performance in demanding clinical environments and enables the creation of sophisticated medical applications.

The SnkeXR glasses are a medical-grade component, engineered and manufactured in full compliance with stringent regulatory and quality standards.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.